The Mumbai-based drug major spent about Rs 2,400 crore on R&D in 2022-23, which accounted for about 5.5 per cent of the sales as it continued to invest product pipeline for both global generics and specialty businesses.
BENGALURU (Reuters) -Sun Pharmaceutical Industries Ltd, India's largest drugmaker, on Tuesday reported a surprise 10.5% rise in second quarter profit .
Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28% SECTIONS Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%ETMarkets.com Last Updated: Jul 30, 2021, 02:33 PM IST Share Synopsis The company’s consolidated revenues in the quarter rose 28 per cent year-on-year to Rs 9,719 crore, which was sharply above analysts’ expectations. Agencies Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter. MUMBAI: Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,444 crore for the quarter ended June as against a consolidated net loss of Rs 1,655 crore in the year-ago quarter. Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter.
Mumbai (Maharashtra) [India], May 27 (ANI): Sun Pharmaceutical Industries on Thursday posted 124 per cent increase in consolidated net profit at Rs 894 crore for the January to March quarter as compared to Rs 400 crore in the year-ago period.
Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief After Nagpur reported a shortage of Remdesivir vaccine, Union minister Nitin Gadkari called up Sun Pharma s chief to arrange for the medicine. advertisement Union minister Nitin Gadkari (Photo: PTI) Union minister Nitin Gadkari has called up Sun Pharma s chief to arrange for 10,000 injections of Remdesivir in Maharashtra s Nagpur in view of a shortage of the medicine in the city. Remdesivir is considered a key anti-viral drug in the fight against Covid-19, especially in adult patients with severe complications. A press release from Gadkari s office on Saturday said the Lok Sabha member from Nagpur spoke to Sun Pharma s Managing Director Dilip Shanghvi over phone to inform him about the situation here and appealed to him to make available the Remdesivir injections.